Patrick Plum
Overview
Explore the profile of Patrick Plum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Markar S, Mariette C, Bonnetain F, Lundell L, Rosati R, De Manzoni G, et al.
Dis Esophagus
. 2025 Jan;
38(1.
PMID: 39863958
Background: Malnutrition is common with esophagogastric cancers and is associated with negative outcomes. We aimed to evaluate if immunonutrition during neoadjuvant treatment improves patient's health-related quality of life (HRQOL) and...
2.
Leonhardi J, Schnarkowski B, Mehdorn M, Hohn A, Niebisch S, Plum P, et al.
In Vivo
. 2024 Dec;
39(1):353-359.
PMID: 39740864
Background/aim: The recently published Node-Reporting and Data System (Node-RADS) can aid the characterization of lymph nodes in cross-sectional imaging. This study investigated the Node-RADS system in computed tomography (CT) to...
3.
Rhode P, Plum P, Gockel I
Chirurgie (Heidelb)
. 2023 May;
94(Suppl 1):18-22.
PMID: 37193937
No abstract available.
4.
Uttinger K, Plum P, Gockel I
Chirurgie (Heidelb)
. 2023 May;
94(Suppl 1):3-7.
PMID: 37171594
No abstract available.
5.
Pisula J, Datta R, Valdez L, Avemarg J, Jung J, Plum P, et al.
Br J Cancer
. 2023 Jan;
128(7):1369-1376.
PMID: 36717673
Background: Fast and accurate diagnostics are key for personalised medicine. Particularly in cancer, precise diagnosis is a prerequisite for targeted therapies, which can prolong lives. In this work, we focus...
6.
Hoppe S, Meder L, Gebauer F, Ullrich R, Zander T, Hillmer A, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230712
Introduction: The Trophoblast cell surface antigen 2 (TROP2) is expressed in many carcinomas and may represent a target for treatment. Sacituzumab govitecan (SG) is a TROP2-directed antibody-drug conjugate (ADC). Nearly...
7.
Damanakis A, Toader J, Wahler I, Plum P, Quaas A, Ernst A, et al.
Br J Surg
. 2022 May;
109(8):746-753.
PMID: 35574811
Background: Recent findings support the hypothesis of sex-related differences in inflammatory and immunological responses to trauma. The aim of this study was to address sex-specific aspects in patients who underwent...
8.
Toader J, Kleinert R, Dratsch T, Fettweis L, Jakovljevic N, Graupner M, et al.
BMC Med Educ
. 2022 Apr;
22(1):295.
PMID: 35443638
Background: The usage of smartphones in the daily clinical routine is an essential aspect however it seems that they also present an important distractor that needs to be evaluated. The...
9.
Brinkmann S, Knepper L, Fuchs H, Hoelscher A, Kuhr K, Pinto Dos Santos D, et al.
Langenbecks Arch Surg
. 2021 Sep;
407(2):569-577.
PMID: 34562118
Purpose: Esophageal perforation is associated with high morbidity and mortality. In addition to surgical treatment, endoscopic endoluminal stent placement and endoscopic vacuum therapy (EVT) are established methods in the management...
10.
Quaas A, Rehkaemper J, Rueschoff J, Pamuk A, Zander T, Hillmer A, et al.
Front Oncol
. 2021 Aug;
11:569475.
PMID: 34367937
Introduction: Knowledge of the high microsatellite-instability (MSI-H)/mismatch repair deficiency (MMRd) status is of increasing interest for personalized neoadjuvant or adjuvant therapy planning. Only a few studies are available on MSI-H...